XML 66 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Deficit (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 22, 2023
Mar. 19, 2023
Feb. 23, 2023
Apr. 15, 2022
Dec. 02, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 07, 2023
Mar. 23, 2023
Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]                    
Warrants outstanding (in shares)           36,344,212 36,964,286      
Common stock, shares issued (in shares)           120,204,513 76,564,396      
Common stock, par value (in dollars per share)           $ 0.001 $ 0.001      
Issuance costs to additional paid in capital   $ 2,900                
Proceeds from issuance of common stock from ATM Program, net of issuance costs           $ 4,448 $ 90,849      
The Warrants                    
Subsidiary, Sale of Stock [Line Items]                    
Exercise price (in dollars per share)   $ 1.55                
Pre Funded Warrant                    
Subsidiary, Sale of Stock [Line Items]                    
Warrants outstanding (in shares)           0        
Adjustment to additional-paid-in-capital for warrants issued   $ 22,800                
Warrants exercised (in shares)           20,965,747        
Warrants                    
Subsidiary, Sale of Stock [Line Items]                    
Warrants exercised (in shares)           5,850,747        
Wainwright                    
Subsidiary, Sale of Stock [Line Items]                    
Warrants outstanding (in shares)         36,964,286 0 36,964,286      
Exercise price (in dollars per share)         $ 9.00 $ 9.00        
Adjustment to additional-paid-in-capital for warrants issued         $ 61,900          
Warrants expired (in shares)               27,940,074    
Securities Purchase Agreement                    
Subsidiary, Sale of Stock [Line Items]                    
Warrants outstanding (in shares)           27,320,000 0      
Exercise price (in dollars per share)           $ 1.55        
Common stock, shares issued (in shares)   12,205,000                
Common stock, par value (in dollars per share)   $ 0.001                
Common stock purchasable under prefunded warrants (in shares)   20,965,747                
Common stock purchasable under warrants (in shares)   33,170,747                
Securities Purchase Agreement | Common Stock And Accompanying Warrant                    
Subsidiary, Sale of Stock [Line Items]                    
Purchase price (in dollars per share)   $ 1.675                
Securities Purchase Agreement | Pre Funded Warrant And Accompanying Warrant                    
Subsidiary, Sale of Stock [Line Items]                    
Purchase price (in dollars per share)   $ 1.674                
Warrant Amendment Agreements                    
Subsidiary, Sale of Stock [Line Items]                    
Net proceeds $ 55,500 $ 1,200                
Warrants outstanding (in shares)           9,024,212 0      
Exercise price (in dollars per share) $ 1.55         $ 1.55     $ 1.55 $ 9.00
Common stock purchasable under warrants (in shares) 9,024,212                  
Warrants exercisable into stock (in shares)   9,024,212                
Additional consideration per amended warrant (in dollars per share) $ 0.125                  
Estimated offering expenses   $ 4,200                
Proceeds from issuance of common stock from ATM Program, net of issuance costs   $ 51,300                
Placement fees $ 100                  
Proceeds from warrant amendment $ 1,100                  
At The Market Program                    
Subsidiary, Sale of Stock [Line Items]                    
Authorized amount     $ 70,000 $ 239,000            
Issued stock (in shares)           3,312,908 13,043,797      
Net proceeds           $ 4,400 $ 90,800      
Payments of stock issuance costs           $ 400 $ 3,100